Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $5.86 billion. The enterprise value is $7.57 billion.
Market Cap | 5.86B |
Enterprise Value | 7.57B |
Important Dates
The next confirmed earnings date is Wednesday, April 23, 2025, before market open.
Earnings Date | Apr 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TMHC has 101.74 million shares outstanding. The number of shares has decreased by -3.00% in one year.
Current Share Class | 101.74M |
Shares Outstanding | 101.74M |
Shares Change (YoY) | -3.00% |
Shares Change (QoQ) | -0.82% |
Owned by Insiders (%) | 2.64% |
Owned by Institutions (%) | 98.95% |
Float | 99.01M |
Valuation Ratios
The trailing PE ratio is 6.96 and the forward PE ratio is 6.40.
PE Ratio | 6.96 |
Forward PE | 6.40 |
PS Ratio | 0.74 |
Forward PS | 0.69 |
PB Ratio | 1.00 |
P/TBV Ratio | 1.13 |
P/FCF Ratio | 33.72 |
P/OCF Ratio | 27.89 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 43.58.
EV / Earnings | 8.57 |
EV / Sales | 0.93 |
EV / EBITDA | 5.89 |
EV / EBIT | 6.09 |
EV / FCF | 43.58 |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.37.
Current Ratio | 6.51 |
Quick Ratio | 0.59 |
Debt / Equity | 0.37 |
Debt / EBITDA | 1.69 |
Debt / FCF | 12.66 |
Interest Coverage | 93.37 |
Financial Efficiency
Return on equity (ROE) is 15.82% and return on invested capital (ROIC) is 10.02%.
Return on Equity (ROE) | 15.82% |
Return on Assets (ROA) | 8.65% |
Return on Invested Capital (ROIC) | 10.02% |
Return on Capital Employed (ROCE) | 15.33% |
Revenue Per Employee | $2.92M |
Profits Per Employee | $315,468 |
Employee Count | 2,800 |
Asset Turnover | 0.91 |
Inventory Turnover | 1.03 |
Taxes
In the past 12 months, TMHC has paid $269.55 million in taxes.
Income Tax | 269.55M |
Effective Tax Rate | 23.31% |
Stock Price Statistics
The stock price has decreased by -1.99% in the last 52 weeks. The beta is 1.76, so TMHC's price volatility has been higher than the market average.
Beta (5Y) | 1.76 |
52-Week Price Change | -1.99% |
50-Day Moving Average | 61.97 |
200-Day Moving Average | 64.40 |
Relative Strength Index (RSI) | 38.25 |
Average Volume (20 Days) | 1,094,089 |
Short Selling Information
The latest short interest is 1.97 million, so 1.94% of the outstanding shares have been sold short.
Short Interest | 1.97M |
Short Previous Month | 2.84M |
Short % of Shares Out | 1.94% |
Short % of Float | 1.99% |
Short Ratio (days to cover) | 1.64 |
Income Statement
In the last 12 months, TMHC had revenue of $8.17 billion and earned $883.31 million in profits. Earnings per share was $8.27.
Revenue | 8.17B |
Gross Profit | 2.01B |
Operating Income | 1.24B |
Pretax Income | 968.08M |
Net Income | 883.31M |
EBITDA | 1.28B |
EBIT | 1.24B |
Earnings Per Share (EPS) | $8.27 |
Balance Sheet
The company has $487.15 million in cash and $2.20 billion in debt, giving a net cash position of -$1.71 billion or -$16.83 per share.
Cash & Cash Equivalents | 487.15M |
Total Debt | 2.20B |
Net Cash | -1.71B |
Net Cash Per Share | -$16.83 |
Equity (Book Value) | 5.88B |
Book Value Per Share | 57.38 |
Working Capital | 6.54B |
Cash Flow
In the last 12 months, operating cash flow was $210.08 million and capital expenditures -$36.33 million, giving a free cash flow of $173.75 million.
Operating Cash Flow | 210.08M |
Capital Expenditures | -36.33M |
Free Cash Flow | 173.75M |
FCF Per Share | $1.71 |
Margins
Gross margin is 24.65%, with operating and profit margins of 15.22% and 10.81%.
Gross Margin | 24.65% |
Operating Margin | 15.22% |
Pretax Margin | 14.15% |
Profit Margin | 10.81% |
EBITDA Margin | 15.73% |
EBIT Margin | 15.22% |
FCF Margin | 2.13% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.00% |
Shareholder Yield | 3.00% |
Earnings Yield | 15.08% |
FCF Yield | 2.97% |
Analyst Forecast
The average price target for TMHC is $79.43, which is 37.92% higher than the current price. The consensus rating is "Buy".
Price Target | $79.43 |
Price Target Difference | 37.92% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 3.96 and a Piotroski F-Score of 6.
Altman Z-Score | 3.96 |
Piotroski F-Score | 6 |